Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 18.6 USD -1.54%
Market Cap: 498.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 29.58 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

ETON Lowest Forecast
Wall Street Target
26.26 USD
41% Upside
ETON Average Forecast
Wall Street Target
29.58 USD
59% Upside
ETON Highest Forecast
Wall Street Target
36.75 USD
98% Upside
Lowest
Price Target
26.26 USD
41% Upside
Average
Price Target
29.58 USD
59% Upside
Highest
Price Target
36.75 USD
98% Upside
Eton Pharmaceuticals Inc Competitors:
Price Targets
S
SDZ
Sandoz Group AG
6% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
24% Upside
C
000661
Changchun High & New Technology Industries Group Inc
4% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
15% Upside
S
SDZ
Sandoz Group AG
6% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
24% Upside
C
000661
Changchun High & New Technology Industries Group Inc
4% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
15% Upside
J
600380
Joincare Pharmaceutical Group Industry Co Ltd
25% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
23% Upside
VIRP
Virbac SA
16% Upside
NUVB
Nuvation Bio Inc
277% Upside

Revenue
Forecast

Revenue Estimate
Eton Pharmaceuticals Inc

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 59%.

N/A
Past Growth
59%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
ETON intrinsic value, competitors valuation, and company profile.
DCF Valuation
ETON stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ETON stock valuation using valuation multiples.
Wall Street Estimates
ETON price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ETON stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
29.58 USD

According to Wall Street analysts, the average 1-year price target for ETON is 29.58 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
59%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 59%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.